CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

August 7, 2024 · earnings

SYRE earnings: a negative outcome, -5.7%

On August 7, 2024, Spyre Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.7% in the window around the event.

The move

$26.04
1d before
$24.55
Event day
$25.25
1d after
$24.31
5d after

Pre-catalyst setup

-1.0%
30-day run-up
5778%
30-day volatility
0.7×
volume spike